胚系致病性变异携带者前列腺癌的临床与MRI特征
本研究为单中心回顾性病例对照研究,比较62例携带胚系致病性变异的前列腺癌患者与246例散发对照的临床、病理及MRI特征。结果显示变异携带者PI-RADS 5评分比例更高,Grade 3前列腺外侵犯更常见,前列腺切除术后病理升级比例更大。
要点
- 胚系致病性变异携带者更常表现为PI-RADS 5分,影像侵袭性更强。
- 携带者Grade 3前列腺外侵犯比例更高,风险约为对照3倍。
- 携带者术后病理升级更常见,影像-病理一致性需谨慎评估。
核心结论
- 胚系致病性变异携带者的前列腺癌影像表现更具侵袭性,且前列腺切除术后病理升级可能性更大。
研究设计与样本
- 单中心回顾性病例对照研究,纳入62例携带≥1个胚系致病性变异且确诊前列腺癌并行MRI检查的患者,与246例连续确诊前列腺癌的对照比较。
- 连续变量采用Mann-Whitney U检验,分类变量采用Fisher精确检验。
关键影像表现/征象
- 携带者与对照的MRI阳性率(PI-RADS≥3)差异无统计学意义(98% vs 96%,p=0.70)。
- 最常见的胚系致病性变异基因为CHEK2(21.0%)、BRCA2(19.4%)、Lynch综合征相关基因(17.7%)及ATM(17.7%)。
诊断标准与关键数值
- MRI阳性定义为PI-RADS≥3,两组阳性率差异无统计学意义(98% vs 96%,p=0.70)。
- 前列腺切除术后病理升级至高分级组的比例携带者为37%,对照为20%(p=0.046)。
- 携带者中位确诊年龄65岁(IQR 58-71),对照67岁(IQR 61-73),p=0.05,差异未达预设显著性。
临床应用与阅片要点
- 放射科医生应了解遗传性前列腺癌的影像侵袭性更强,对胚系变异携带者需更细致评估前列腺外侵犯。
- 对PI-RADS 5分且伴明显前列腺外侵犯的年轻患者,可提示临床考虑胚系基因检测。
- 携带者术后病理升级比例高,术前MRI风险分层时应意识到可能的低估风险。
局限性
- 单中心回顾性设计,存在选择偏倚和信息偏倚可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Compare the clinical and imaging features of prostate cancer (PCa) patients harboring a germline pathogenic variant (PV) to sporadic controls.
MATERIALS AND METHODS: A single-center retrospective case-control study was performed by identifying patients with positive germline genetic testing for a PV diagnosed with prostate cancer between December 2015 and October 2025. Clinical, pathologic, and MRI characteristics of PV carriers were compared to a control group of consecutive patients diagnosed with PCa over 1 year. Mann-Whitney U-test was used for continuous data and Fisher's exact test for categorical comparisons.
RESULTS: A total of 62 patients with PCa harboring ≥ 1 PV and an MRI at diagnosis were compared to 246 controls. The most frequent genes were Lynch syndrome (LS) associated (17.7%), CHEK2 (21.0%), ATM (17.7%), and BRCA2 (19.4%). Median age of PV carriers was not significantly younger than controls at diagnosis (65 years [IQR, 58-71], vs 67 years [61-73], p = 0.05). The proportion of patients with a positive MRI (PI-RADS ≥ 3) did not differ between groups (98% PV vs 96% control, p = 0.70). PV carriers were more likely to receive a PI-RADS 5 score (OR: 2.7; CI: 1.5-4.9, p < 0.01) and grade 3 extra-prostatic extension (OR: 3.0; CI: 1.5-5.8, p < 0.01). At prostatectomy, the proportion of patients reclassified to a higher-grade group was larger for PV carriers (37% vs 20%, p = 0.046).
CONCLUSION: PV carriers with PCa tend to manifest more aggressive imaging findings and are more likely to experience pathologic upgrading at prostatectomy.
KEY POINTS: Question Differences in the clinical and imaging characteristics of sporadic prostate cancer (PCa) patients compared to patients harboring a PCa-associated germline pathogenic variant remain understudied. Findings PV carriers with PCa manifest more aggressive imaging features and are more likely to demonstrate pathologic upgrading at prostatectomy. Clinical relevance Knowledge of the unique clinical and imaging manifestations of hereditary PCa should support ongoing early detection studies and underscore the need for radiologists to be familiar with patient-centered early detection strategies utilizing MRI.
引用
- Cochran, Parameswaran, Nakrour, et al. Clinical and MRI characteristics of germline pathogenic variant carriers diagnosed with prostate cancer. Eur Radiol. 2026. PMID: 42806037. doi:10.1007/s00330-026-12918-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。